SIMILAR MARKET STUDIES
Summary CASI Pharmaceuticals Inc. (CASI), formerly EntreMed, Inc is a clinical-stage pharmaceutical company. It develops therapeutics for the treatment of cancer and inflammatory diseases. The companys lead compound, ENMD-2076, a selective angiogenic kinase inhibitor, has completed several Phase 1 studies in solid tumors, multiple myeloma and leukemia, and is conducting a ...
April 2015 | $250 | View Details >>
Age Related Macular Degeneration - Pipeline Review, H2 2015 Summary Global Markets Directs, Age Related Macular Degeneration - Pipeline Review, H2 2015, provides an overview of the Age Related Macular Degenerations therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Age Related Macular Degeneration, complete with comparative analysis at various ...
December 2015 | $2000 | View Details >>
This report presents data on the Breath Fresheners (non-confectionery) consumption trends in Portugal. It analyzes Breath Fresheners (non-confectionery) consumption volumes and values at market and category level. It examines the components of change in the market for the historic (2007-2012) and forecast (2013-2017) years by volumes and values, as well as the manner in which changes in consumer behavior have affected total volumes, values and the type of products chosen.
December 2013 | $200 | View Details >>
Summary Vantage Oncology, Inc. (Vantage Oncology) is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates 63 cancer treatment facilities in 15 states. Vantage Oncology provides treatment for bone, brain, breast, gastrointestinal, gynecological, prostate, skin, and lung cancer. The company’s medical oncology includes initial consultation, ...
August 2015 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research